Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
In the mid-afternoon, the pharmaceutical company is making no progress while the Paris stock market shows significant gains. The stock continues to su…
On Thursday, the FDA granted a priority review for the approval of venglustat to treat type 3 Gaucher's disease in the United States. If approved, thi…
Sanofi shares rise by 1.77% to €76.53 mid-session, as the CAC 40 gains 0.73%. The company is among the top performers on the CAC 40 following the posi…
Sanofi announced on Monday the results of the phase 2 ElevAATe study evaluating efdoralprin alfa, an experimental treatment for patients with emphysem…
Sanofi shares fell by 1.04% to €72.46 in mid-morning trading, after hitting €71.73 during the session, marking a new six-year low. This level surpasse…
Sanofi shares fell by 0.92% to €73.06 in mid-afternoon trading. During the session, the stock touched €72.78, a new low since the 2020 Covid-19 crash …
On Tuesday, Sanofi shares recorded a new six-year low during the session, dropping to €74.21, a level not seen since the Covid-19 crash of 2020. By mi…
Sanofi's stock declines in early afternoon, affected by a downgrade issued on the same day by Morgan Stanley. The movement occurs in a Parisian market…
Sanofi announced on Friday the successful placement of a €2.3 billion bond issue in three tranches, as part of its Euro Medium Term Note program. The …
The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending the approval of Cenrifk…
